Reporte zur Charge G05NG

Symptomtext

hive marks in back area; Round and raise marks/ had 8 to 9 large marks ? inch wide/ 2 or 3 large marks at least 2 inches wide; marks were stinging; This case was reported by a consumer via call center representative and described the occurrence of hives in a 20-year-old male patient who received DTPa (Reduced antigen) (Boostrix) (batch number G05NG, expiry date unknown) for prophylaxis. On an unknown date, the patient received Boostrix. On an unknown date, unknown after receiving Boostrix, the patient experienced hives, raised rash and stinging. On an unknown date, the outcome of the hives, raised rash and stinging were unknown. It was unknown if the reporter considered the hives, raised rash and stinging to be related to Boostrix. Additional details were provided as follows: The case was reported by patient's parent. The age at vaccination was not reported. The patient received Boostrix vaccine in the right arm and experienced few hive marks in the back area, the marks were round and raise the patient had 8 to 9 large marks ? inch wide and the marks were stinging. The reporter did not consent to follow up